IN2013MU03034A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03034A
IN2013MU03034A IN3034MU2013A IN2013MU03034A IN 2013MU03034 A IN2013MU03034 A IN 2013MU03034A IN 3034MU2013 A IN3034MU2013 A IN 3034MU2013A IN 2013MU03034 A IN2013MU03034 A IN 2013MU03034A
Authority
IN
India
Prior art keywords
compositions
micronised
eggshell
processes
preparation
Prior art date
Application number
Inventor
Sachin Shyamsundar Laddha
Sandeep Onkar Waghulde
Nagesh Parmeshwar Hange
Niranjan Vijay Patil
Hiren Manji Patel
Mrinal Vivekanand Sikdar
Manojkumar Sarangi
Ajit Hasha Patil
Amit Ramchandra Kumabhar
Original Assignee
Sachin Shyamsundar Laddha
Sandeep Onkar Waghulde
Nagesh Parmeshwar Hange
Niranjan Vijay Patil
Hiren Manji Patel
Mrinal Vivekanand Sikdar
Manojkumar Sarangi
Ajit Hasha Patil
Kumbhar Amit Ramchandra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sachin Shyamsundar Laddha, Sandeep Onkar Waghulde, Nagesh Parmeshwar Hange, Niranjan Vijay Patil, Hiren Manji Patel, Mrinal Vivekanand Sikdar, Manojkumar Sarangi, Ajit Hasha Patil, Kumbhar Amit Ramchandra filed Critical Sachin Shyamsundar Laddha
Priority to IN3034MU2013 priority Critical patent/IN2013MU03034A/en
Publication of IN2013MU03034A publication Critical patent/IN2013MU03034A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides effervescent immediate release drug compositions comprising combination of Micronised Eggshell & stabilized Vitamin D3, processes for their preparation; and methods of using such compositions as calcium supplement.
IN3034MU2013 2013-09-20 2013-09-20 IN2013MU03034A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3034MU2013 IN2013MU03034A (en) 2013-09-20 2013-09-20

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3034MU2013 IN2013MU03034A (en) 2013-09-20 2013-09-20

Publications (1)

Publication Number Publication Date
IN2013MU03034A true IN2013MU03034A (en) 2015-07-10

Family

ID=54397086

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3034MU2013 IN2013MU03034A (en) 2013-09-20 2013-09-20

Country Status (1)

Country Link
IN (1) IN2013MU03034A (en)

Similar Documents

Publication Publication Date Title
MX2022012374A (en) Multi-supplement compositions.
PH12016501122A1 (en) Delayed release compositions of linaclotide
MX2016016666A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2016015093A (en) Boronic acid derivatives and therapeutic uses thereof.
PH12016501578A1 (en) Pharmaceutical compounds
JOP20140114B1 (en) Heterocyclic compounds and their uses
MD20170048A2 (en) Abiraterone acetate formulation and methods of use
PH12016501686A1 (en) Pharmaceutical compositions of sitagliptin
MX2013002948A (en) Pharmaceutical and nutraceutical compositions of abscisic acid.
WO2013134534A3 (en) Solid state forms of cabazitaxel and processes for preparation thereof
MX345926B (en) Novel compositions, preparation thereof and use thereof for production of cast polyamides.
IN2013MU03641A (en)
MX2015012416A (en) Heterocyclic compounds and their uses.
MX2016001422A (en) Pharmaceutical compositions of fingolimod.
SG11201605868XA (en) Pharmaceutical composition for cancer treatment and pharmaceutical preparation for cancer treatment containing same composition as active ingredient
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
PH12017500348B1 (en) Tetrahydroquinoline derivatives as bromodomain inhibitors
MX2017009289A (en) Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same.
IN2014CH00840A (en)
MX2016000219A (en) Dihydroxyphenyl neurotransmitter compounds, compositions and methods.
SG11201608845PA (en) Cosmetic composition containing mentha haplocalyx as active ingredient
MX2016003207A (en) Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation.
MX2016002930A (en) Liver x receptor (lxr) modulators.
PH12019500024A1 (en) Pharmaceutical compositions
NZ721832A (en) Solid forms of tenofovir